Does cannabis use influence opioid outcomes and quality of life among buprenorphine maintained patients?

8/1/18–A recent study, published in the Journal of Addiction Medicine, aimed to assess the pattern of cannabis use among opioid-dependent patients maintained on buprenorphine. Additionally, the study compared the dose of buprenorphine, opioid-related craving and withdrawals, productivity, and quality of life between those with and without recent (past 90-day) cannabis use. The study concluded that cannabis use does not negatively influence opioid outcomes among patients receiving buprenorphine maintenance treatment.  Furthermore, there is no difference in productivity and quality of life between individuals maintained on buprenorphine with and without current cannabis use. Read